Inspire Medical Net Worth

Inspire Medical Net Worth Breakdown

  INSP
The net worth of Inspire Medical Systems is the difference between its total assets and liabilities. Inspire Medical's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Inspire Medical's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Inspire Medical's net worth can be used as a measure of its financial health and stability which can help investors to decide if Inspire Medical is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Inspire Medical Systems stock.

Inspire Medical Net Worth Analysis

Inspire Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Inspire Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Inspire Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Inspire Medical's net worth analysis. One common approach is to calculate Inspire Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Inspire Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Inspire Medical's net worth. This approach calculates the present value of Inspire Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Inspire Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Inspire Medical's net worth. This involves comparing Inspire Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Inspire Medical's net worth relative to its peers.

Enterprise Value

5.48 Billion

To determine if Inspire Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Inspire Medical's net worth research are outlined below:
Inspire Medical had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 624.8 M. Net Loss for the year was (21.15 M) with profit before overhead, payroll, taxes, and interest of 640.54 M.
Over 98.0% of the company shares are owned by institutional investors
Latest headline from gurufocus.com: Inspire Medical Systems Inc Stock Price Up 3.11 percent on Jan 15
Inspire Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Inspire Medical Systems. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Inspire Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
6th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know Inspire Medical's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Inspire Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Inspire Medical Systems backward and forwards among themselves. Inspire Medical's institutional investor refers to the entity that pools money to purchase Inspire Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Norges Bank Usd2024-06-30
278 K
Norges Bank Usd2024-06-30
278 K
Fmr Inc2024-09-30
2.9 M
Wellington Management Company Llp2024-09-30
1.4 M
Baillie Gifford & Co Limited.2024-09-30
1.4 M
Bank Of New York Mellon Corp2024-09-30
772.8 K
Amvescap Plc.2024-09-30
694 K
Macquarie Investment Management Aus Ltd.2024-09-30
582.3 K
Geode Capital Management, Llc2024-09-30
483.7 K
Champlain Investment Partners, Llc2024-09-30
464.6 K
Brown Capital Management, Llc2024-09-30
350.5 K
Note, although Inspire Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Inspire Medical's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.67 B.

Market Cap

5.63 Billion

Project Inspire Medical's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.03)(0.03)
Return On Capital Employed(0.06)(0.06)
Return On Assets(0.03)(0.03)
Return On Equity(0.03)(0.03)
The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.
When accessing Inspire Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Inspire Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Inspire Medical's profitability and make more informed investment decisions.

Evaluate Inspire Medical's management efficiency

Inspire Medical Systems has return on total asset (ROA) of 0.0118 % which means that it generated a profit of $0.0118 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0533 %, meaning that it created $0.0533 on every $100 dollars invested by stockholders. Inspire Medical's management efficiency ratios could be used to measure how well Inspire Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of 01/23/2025, Return On Tangible Assets is likely to drop to -0.03. In addition to that, Return On Capital Employed is likely to drop to -0.06. At this time, Inspire Medical's Total Current Liabilities is relatively stable compared to the past year. As of 01/23/2025, Liabilities And Stockholders Equity is likely to grow to about 817.2 M, while Non Current Liabilities Total is likely to drop slightly above 23.1 M.
Last ReportedProjected for Next Year
Book Value Per Share 17.58  18.46 
Tangible Book Value Per Share 17.58  18.46 
Enterprise Value Over EBITDA(390.99)(371.44)
Price Book Value Ratio 11.97  11.37 
Enterprise Value Multiple(390.99)(371.44)
Price Fair Value 11.97  11.37 
Enterprise Value5.2 B5.5 B
Leadership at Inspire Medical emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Enterprise Value Revenue
6.9873
Revenue
755.6 M
Quarterly Revenue Growth
0.325
Revenue Per Share
25.453
Return On Equity
0.0533
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Inspire Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Inspire Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Inspire Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Timothy Herbert over three months ago
Disposition of 3379 shares by Timothy Herbert of Inspire Medical at 206.19 subject to Rule 16b-3
 
John Rondoni over three months ago
Acquisition by John Rondoni of 5000 shares of Inspire Medical at 71.0 subject to Rule 16b-3
 
John Rondoni over three months ago
Disposition of 5000 shares by John Rondoni of Inspire Medical at 71.0 subject to Rule 16b-3
 
Ban Randy over three months ago
Disposition of 4861 shares by Ban Randy of Inspire Medical at 42.15 subject to Rule 16b-3
 
Ban Randy over three months ago
Disposition of 2350 shares by Ban Randy of Inspire Medical at 194.91 subject to Rule 16b-3
 
Shawn McCormick over three months ago
Disposition of 7518 shares by Shawn McCormick of Inspire Medical at 0.94 subject to Rule 16b-3
 
Melissa Mann over three months ago
Acquisition by Melissa Mann of 3190 shares of Inspire Medical subject to Rule 16b-3
 
Shelley Broader over six months ago
Acquisition by Shelley Broader of 117 shares of Inspire Medical at 138.58 subject to Rule 16b-3
 
Jerry Griffin over six months ago
Disposition of tradable shares by Jerry Griffin of Inspire Medical at 213.99 subject to Rule 16b-3
 
Sparks Charisse Y over six months ago
Disposition of tradable shares by Sparks Charisse Y of Inspire Medical subject to Rule 16b-3
 
Gary Ellis over six months ago
Acquisition by Gary Ellis of 716 shares of Inspire Medical subject to Rule 16b-3
 
Shawn McCormick over six months ago
Acquisition by Shawn McCormick of 716 shares of Inspire Medical subject to Rule 16b-3

Inspire Medical Corporate Filings

F4
17th of January 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
13th of January 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
4th of October 2024
An amended filing to the original Schedule 13G
ViewVerify
F3
1st of August 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
Inspire Medical time-series forecasting models is one of many Inspire Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Inspire Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Inspire Medical Earnings per Share Projection vs Actual

Inspire Medical Corporate Directors

Georgia GarinoisMelenikiotouIndependent DirectorProfile
Megan CPADirector ReportingProfile
Shawn McCormickIndependent DirectorProfile
Jerry GriffinIndependent DirectorProfile

Additional Tools for Inspire Stock Analysis

When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.